AAAAAA

   
Results: 1-10 |
Results: 10
Minimal in vivo activation of CYP2C9-mediated flurbiprofen metabolism by dapsone
Authors: Hutzler, JM Frye, RF Korzekwa, KR Branch, RA Huang, SM Tracy, TS
Citation: Jm. Hutzler et al., Minimal in vivo activation of CYP2C9-mediated flurbiprofen metabolism by dapsone, EUR J PH SC, 14(1), 2001, pp. 47-52
A kinetic model for the metabolic interaction of two substrates at the active site of cytochrome P450 3A4
Authors: Shou, M Dai, R Cui, D Korzekwa, KR Baillie, TA Rushmore, TH
Citation: M. Shou et al., A kinetic model for the metabolic interaction of two substrates at the active site of cytochrome P450 3A4, J BIOL CHEM, 276(3), 2001, pp. 2256-2262
Evaluation of the mechanism of aromatase cytochrome P450 - A site-directedmutagenesis study
Authors: Kao, YC Korzekwa, KR Laughton, CA Chen, S
Citation: Yc. Kao et al., Evaluation of the mechanism of aromatase cytochrome P450 - A site-directedmutagenesis study, EUR J BIOCH, 268(2), 2001, pp. 243-251
An assessment of the reaction energetics for cytochrome P450-mediated reactions
Authors: Higgins, L Korzekwa, KR Rao, S Shou, MG Jones, JP
Citation: L. Higgins et al., An assessment of the reaction energetics for cytochrome P450-mediated reactions, ARCH BIOCH, 385(1), 2001, pp. 220-230
The human CYP3A subfamily: Practical considerations
Authors: Wrighton, SA Schuetz, EG Thummel, KE Shen, DD Korzekwa, KR Watkins, PB
Citation: Sa. Wrighton et al., The human CYP3A subfamily: Practical considerations, DRUG METAB, 32(3-4), 2000, pp. 339-361
Use of inhibitory monoclonal antibodies to assess the contribution of cytochromes P450 to human drug metabolism
Authors: Shou, MG Lu, T Krausz, KW Sai, Y Yang, TJ Korzekwa, KR Gonzalez, FJ Gelboin, HV
Citation: Mg. Shou et al., Use of inhibitory monoclonal antibodies to assess the contribution of cytochromes P450 to human drug metabolism, EUR J PHARM, 394(2-3), 2000, pp. 199-209
Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms
Authors: Dubey, RK Gillespie, DG Zacharia, LC Rosselli, M Korzekwa, KR Fingerle, J Jackson, EK
Citation: Rk. Dubey et al., Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms, BIOC BIOP R, 278(1), 2000, pp. 27-33
Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil
Authors: Tracy, TS Korzekwa, KR Gonzalez, FJ Wainer, IW
Citation: Ts. Tracy et al., Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil, BR J CL PH, 47(5), 1999, pp. 545-552
Structural forms of phenprocoumon and warfarin that are metabolized at theactive site of CYP2C9
Authors: He, MX Korzekwa, KR Jones, JP Rettie, AE Trager, WF
Citation: Mx. He et al., Structural forms of phenprocoumon and warfarin that are metabolized at theactive site of CYP2C9, ARCH BIOCH, 372(1), 1999, pp. 16-28
The cytochrome P450 suicide inhibitor, 1-aminobenzotriazole, sensitizes rats to zymosan-induced toxicity
Authors: Carcillo, JA Korzekwa, KR Jones, GS Parise, RA Gillespie, DG Whalen, MJ Kochanek, PM Branch, RA Kost, CK
Citation: Ja. Carcillo et al., The cytochrome P450 suicide inhibitor, 1-aminobenzotriazole, sensitizes rats to zymosan-induced toxicity, RES COM M P, 102(1), 1998, pp. 57-68
Risultati: 1-10 |